Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (284)	3/7/2007 10:39:56 PM
From: Mike McFarland	Respond to of 360

51,119 shares each--they might simply have issued those shares to themselves, but they each hold a decent pack of shares and that is something. Either way, you wont see me getting wildly enthusiastic about glgc til our CD comes due and I get the chance to reload. You know, etrade sux a little bit: They received our paperwork eight days ago and still have not set up my wife's CD. A 5% CD seemed a great idea when the market was down, but it may not end up being worth the hassle--and I may miss good trades too. Seldom have we been in cash in this particular account, and while we wait for them to set up the CD I come to find out they are only paying 2% on the money market. I had to request a different higher paying money market ("Sweepmax") and who knows how long that will take. Etrade is very inefficient as far as I can tell.

To: Steve Lokness who wrote (284)	3/8/2007 4:15:01 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 360

I looked up the transaction codes, here's the document: sec.gov Most of the codes in block 3 are a "P" Open market or private purchase of non-derivative or derivative security If you skip down to Tartaglia's code, it is an "A" Grant, award or other acquisition pursuant to Rule 16b-3(d) Do I see this right? Lloyd I. Miller III is up to owning 14.3% of the shares now. Well, it seems a little odd to announce on your call that you're not expecting decisions or milestones this year and right away go bullish on your own shares. Maybe I outfoxed myself on this, time will tell whether I left a lot of money on the table. I did own quite a lot of shares and that in and of itself was a little hairy. I might have sold half and just let the rest ride along with a mental stop loss--that might have been better than fleeing into cash. I expect at the end of the year glgc will have $30m in the bank, so it is trading at twice year end cash (I am totally guessing on that number). fwiw, those other two: ands will have $50m, and infi around $100m so they each trade right now at 2x and 2.4x end of year cash. Those are good estimates. So, none of these stocks are "free" but none seems expensive. Now, how much value you assign to each leadership team and the scientific talent I've only a rough idea. And as far as the various molecules, of course I am clueless. It is fun to dabble a bit--happily this is a quiet thread and nobody seems to mind me here!